EPA-话题@MedSci

#EPA#

1120篇内容 | 2824人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1427174, encodeId=cd60142e174f9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：Risankizumab治疗中重度克伦恩病效果显著, objectType=article, longId=145292, objectId=3771145292bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3771145292bc, replyNumber=0, likeNumber=27, createdTime=2018-07-28, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3771145292bc, moduleTitle=Lancet Gastroen Hepatol：Risankizumab治疗中重度克伦恩病效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3771145292bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427173, encodeId=44c0142e1735d, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：非重度饮酒，尤其是中度饮酒，与非侵入性纤维化标志物的恶化有显著且独立的相关性, objectType=article, longId=145284, objectId=785014528431, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=785014528431, replyNumber=0, likeNumber=55, createdTime=2018-07-28, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=785014528431, moduleTitle=Hepatology：非重度饮酒，尤其是中度饮酒，与非侵入性纤维化标志物的恶化有显著且独立的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=785014528431)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427172, encodeId=ec33142e17204, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：在美国，肝硬化和肝细胞癌的病因学和基于种族的年死亡率的变化趋势, objectType=article, longId=145279, objectId=99421452e9c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99421452e9c3, replyNumber=0, likeNumber=70, createdTime=2018-07-28, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99421452e9c3, moduleTitle=Hepatology：在美国，肝硬化和肝细胞癌的病因学和基于种族的年死亡率的变化趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99421452e9c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427171, encodeId=c17d142e1711f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, objectType=article, longId=145196, objectId=e18514519623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18514519623, replyNumber=0, likeNumber=72, createdTime=2018-07-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18514519623, moduleTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18514519623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427170, encodeId=4734142e170e5, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化, objectType=article, longId=145195, objectId=f7b21451958d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b21451958d, replyNumber=0, likeNumber=61, createdTime=2018-07-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b21451958d, moduleTitle=J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b21451958d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427169, encodeId=efac142e169fb, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化, objectType=article, longId=145194, objectId=003414519441, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003414519441, replyNumber=0, likeNumber=54, createdTime=2018-07-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003414519441, moduleTitle=J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=003414519441)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427168, encodeId=4926142e168e3, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：HEV阳性捐献者的血液制品对免疫缺陷患者来说，具有相关的感染风险, objectType=article, longId=145192, objectId=063714519225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063714519225, replyNumber=0, likeNumber=57, createdTime=2018-07-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063714519225, moduleTitle=J Hepatol：HEV阳性捐献者的血液制品对免疫缺陷患者来说，具有相关的感染风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063714519225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427167, encodeId=fcbc142e167fe, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：DAA治疗晚期肝纤维化的HCV患者，其新生HCC的发生率, objectType=article, longId=145191, objectId=71ff14519145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71ff14519145, replyNumber=0, likeNumber=64, createdTime=2018-07-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71ff14519145, moduleTitle=J Hepatol：DAA治疗晚期肝纤维化的HCV患者，其新生HCC的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71ff14519145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427166, encodeId=458d142e166ca, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Diabetes：选择性Epac激动剂可恢复2型糖尿病胰岛的葡萄糖诱导的Cdc42-Pak1激活和胰岛素分泌, objectType=article, longId=145124, objectId=cdac145124aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdac145124aa, replyNumber=0, likeNumber=26, createdTime=2018-07-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdac145124aa, moduleTitle=Diabetes：选择性Epac激动剂可恢复2型糖尿病胰岛的葡萄糖诱导的Cdc42-Pak1激活和胰岛素分泌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdac145124aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427165, encodeId=dffc142e1657a, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：饮食和化学诱导的小鼠NASH模型，可快速发展为脂肪性肝炎，纤维化和肝癌, objectType=article, longId=145116, objectId=9a5e14511657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a5e14511657, replyNumber=0, likeNumber=78, createdTime=2018-07-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a5e14511657, moduleTitle=J Hepatol：饮食和化学诱导的小鼠NASH模型，可快速发展为脂肪性肝炎，纤维化和肝癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a5e14511657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427164, encodeId=f17c142e1642f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：用液滴数字PCR检测anti-HBc阳性患者肝组织内HBV cccDNA水平, objectType=article, longId=145112, objectId=2a151451126a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a151451126a, replyNumber=0, likeNumber=71, createdTime=2018-07-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a151451126a, moduleTitle=J Hepatol：用液滴数字PCR检测anti-HBc阳性患者肝组织内HBV cccDNA水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a151451126a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427163, encodeId=6d66142e163e9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology:微生物所叶昕研究组在HBV上调的lnc-HUR1调控肝癌发生的机制方面取得进展, objectType=article, longId=144618, objectId=fa2114461867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa2114461867, replyNumber=0, likeNumber=68, createdTime=2018-07-19, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa2114461867, moduleTitle=Hepatology:微生物所叶昕研究组在HBV上调的lnc-HUR1调控肝癌发生的机制方面取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa2114461867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427162, encodeId=f606142e16222, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：外源异生物质被鉴定为原发性胆汁性胆管炎的潜在环境触发因素, objectType=article, longId=144397, objectId=143614439e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=143614439e9e, replyNumber=0, likeNumber=66, createdTime=2018-07-15, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=143614439e9e, moduleTitle=J Hepatol：外源异生物质被鉴定为原发性胆汁性胆管炎的潜在环境触发因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=143614439e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427161, encodeId=3ebc142e161bf, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Gastroen Hepatol：英利昔单抗抢救急性重症溃疡性结肠炎的疗效预测, objectType=article, longId=144200, objectId=6513144200dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6513144200dd, replyNumber=0, likeNumber=55, createdTime=2018-07-13, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6513144200dd, moduleTitle=J Gastroen Hepatol：英利昔单抗抢救急性重症溃疡性结肠炎的疗效预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6513144200dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427160, encodeId=beac142e16007, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastro & Hepatology：TIPS术扩张不足不会导致肝硬化患者相关脑病的发生率升高, objectType=article, longId=142847, objectId=97c814284e04, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c814284e04, replyNumber=0, likeNumber=102, createdTime=2018-07-11, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c814284e04, moduleTitle=Clin Gastro & Hepatology：TIPS术扩张不足不会导致肝硬化患者相关脑病的发生率升高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c814284e04)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427159, encodeId=1aa0142e1596b, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：警惕！糖尿病、血糖与脂肪肝、肝硬化和肝癌发病率的关系, objectType=article, longId=142740, objectId=1457142e4074, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1457142e4074, replyNumber=0, likeNumber=54, createdTime=2018-07-09, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1457142e4074, moduleTitle=Hepatology：警惕！糖尿病、血糖与脂肪肝、肝硬化和肝癌发病率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1457142e4074)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427158, encodeId=77aa142e158c0, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：自身免疫性肝炎的家族发生情况, objectType=article, longId=142735, objectId=22f9142e35f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22f9142e35f6, replyNumber=0, likeNumber=76, createdTime=2018-07-09, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22f9142e35f6, moduleTitle=J Hepatol：自身免疫性肝炎的家族发生情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22f9142e35f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427157, encodeId=5e5d142e1571a, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, objectType=article, longId=142592, objectId=cd51142592a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd51142592a7, replyNumber=0, likeNumber=62, createdTime=2018-07-07, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd51142592a7, moduleTitle=J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd51142592a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427156, encodeId=59cd142e1561b, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：HCV患者获得SVR后，肝脏测试的持续变化并不少见；这与肝硬化和基线瞬时弹性成像数值相关, objectType=article, longId=142591, objectId=e3fa142591fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3fa142591fe, replyNumber=0, likeNumber=83, createdTime=2018-07-07, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3fa142591fe, moduleTitle=J Viral Hepat：HCV患者获得SVR后，肝脏测试的持续变化并不少见；这与肝硬化和基线瞬时弹性成像数值相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3fa142591fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427155, encodeId=5c36142e15552, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：多种突变负担及其他分子标志物对结肠癌预后的影响, objectType=article, longId=142427, objectId=e55014242e8d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55014242e8d, replyNumber=0, likeNumber=83, createdTime=2018-07-05, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55014242e8d, moduleTitle=Lancet Gastroen Hepatol：多种突变负担及其他分子标志物对结肠癌预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e55014242e8d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EPA

2020-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：Risankizumab治疗中重度克伦恩病效果显著

2018-07-28

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：非重度饮酒，尤其是中度饮酒，与非侵入性纤维化标志物的恶化有显著且独立的相关性

2018-07-28

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：在美国，肝硬化和肝细胞癌的病因学和基于种族的年死亡率的变化趋势

2018-07-28

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险

2018-07-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：直接抗病毒药物提高了肝移植后患者的早期生存率，并引起肝移植等待名单的显著变化

2018-07-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：DAA药物治疗清除HCV病毒后可改善严重肝纤维化患者的颈动脉粥样硬化

2018-07-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：HEV阳性捐献者的血液制品对免疫缺陷患者来说，具有相关的感染风险

2018-07-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：DAA治疗晚期肝纤维化的HCV患者，其新生HCC的发生率

2018-07-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Diabetes：选择性Epac激动剂可恢复2型糖尿病胰岛的葡萄糖诱导的Cdc42-Pak1激活和胰岛素分泌

2018-07-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：饮食和化学诱导的小鼠NASH模型，可快速发展为脂肪性肝炎，纤维化和肝癌

2018-07-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：用液滴数字PCR检测anti-HBc阳性患者肝组织内HBV cccDNA水平

2018-07-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology:微生物所叶昕研究组在HBV上调的lnc-HUR1调控肝癌发生的机制方面取得进展

2018-07-19

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：外源异生物质被鉴定为原发性胆汁性胆管炎的潜在环境触发因素

2018-07-15

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Gastroen Hepatol：英利昔单抗抢救急性重症溃疡性结肠炎的疗效预测

2018-07-13

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastro & Hepatology：TIPS术扩张不足不会导致肝硬化患者相关脑病的发生率升高

2018-07-11

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：警惕！糖尿病、血糖与脂肪肝、肝硬化和肝癌发病率的关系

2018-07-09

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：自身免疫性肝炎的家族发生情况

2018-07-09

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：肝硬化、高龄、较高的BMI是获得可持续病毒学应答的晚期肝纤维化HCV患者的危险因素

2018-07-07

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：HCV患者获得SVR后，肝脏测试的持续变化并不少见；这与肝硬化和基线瞬时弹性成像数值相关

2018-07-07

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：多种突变负担及其他分子标志物对结肠癌预后的影响

2018-07-05

科室
- - 订阅+
  - 更多科室
工具
服务